A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy
Enrolling by invitation
Conditions studied: Sarcoma
In brief
The researchers are doing this study to improve their knowledge about immunotherapy use and how effective it is as a treatment for people with sarcoma by collecting information from participants' medical records who have been treated with immune checkpoint blockade or T-cell receptor-based therapy.
Key facts
- Study ID
- NCT06113315
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 250
- Starts
- 2023-10-27
- Expected to finish
- 2028-10-01
- Last updated by the study team
- 2026-08-04
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants must have a histologic diagnosis of sarcoma confirmed by an MSK pathologist.
- Any prospectively identified patient being treated or to be treated with an immune checkpoint inhibitor, such as anti-PD-1, anti-PD-L1, anti-CTLA-4, or anti-LAG3 inhibitor, either as monotherapy or in combination with additional systemic therapy OR any prospectively identified patient being treated or to be treated with ACT-based treatment including but not limited to lifileucil, Afamitresgene autoleucel, and letetresgene autoleuce o Novel immune checkpoints inhibitors that are developed after submission of this protocol will also be included) Please Note: there is no age requirement. Patients of all ages are eligible to enroll
You may not qualify if…
- Patient unwilling to consent to collection of historical and longitudinal clinicopathologic data in the patient medical record from baseline (the period prior to ICB or ACT initiation), during, and after ICB or ACT treatment
Where it is running
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) — Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) — Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (All Protocol Activities) — Commack, New York, United States
- Memorial Sloan Kettering Westchester (All Protocol Activities) — East White Plains, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Memorial Sloan Kettering Nassau (All Protocol Activities) — Uniondale, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.